{"meta":{"query_hash":"d75fef24b96f","filters":{"venue":"Journal of Controversies in Biomedical Research"},"cohort_total":3,"direct_labels_cover":0,"predictions_cover":3,"exported":3,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/d75fef24b96f","api":"https://metacan.xera.ac/api/v1/cohort?venue=Journal+of+Controversies+in+Biomedical+Research"},"results":[{"id":"W2148619961","doi":"10.15586/jcbmr.2015.3","title":"Disparity of outcomes: the limits of modeling amyotrophic lateral sclerosis in murine models and translating results clinically","year":2015,"lang":"en","type":"article","venue":"Journal of Controversies in Biomedical Research","topic":"Amyotrophic Lateral Sclerosis Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Amyotrophic lateral sclerosis; SOD1; Clinical trial; Medicine; Disease; Population; Intensive care medicine; Etiology; Drug development; Bioinformatics; Neuroscience; Pathology; Psychology; Biology; Psychiatry; Drug; Environmental health","score_opus":0.3034189456163247,"score_gpt":0.44593882720426664,"score_spread":0.14251988158794193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2148619961","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011178321,0.58536243,0.0915718,0.26906094,0.0125156585,0.0006192569,0.0015961002,0.0008312526,0.02726432],"genre_scores_gemma":[0.13134153,0.6553814,0.08585859,0.10199711,0.01576253,0.0030922801,0.0014463947,0.00089952693,0.004220618],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.977874,0.013241014,0.0023932494,0.001908921,0.0040277042,0.0005552245],"domain_scores_gemma":[0.9171075,0.06544832,0.0035570085,0.0058784694,0.0067367074,0.0012720462],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.067356005,0.0011149229,0.0021546942,0.0012087782,0.00091132463,0.0064945123,0.0037685488,0.0044157067,0.0039016106],"category_scores_gemma":[0.08752668,0.0005109415,0.001452042,0.0009766202,0.0063047977,0.008216522,0.004392814,0.0090967165,0.0018067335],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010591804,0.00040112663,0.0041911257,0.013743604,0.0008076072,0.00067531824,0.0014002932,0.0030229765,0.008158488,0.29091465,0.06571454,0.60991114],"study_design_scores_gemma":[0.00025343278,0.0016819332,0.0034057847,0.01649567,0.00096427737,0.0012259504,0.0013793067,0.0024578415,0.00703691,0.31551233,0.6493708,0.00021579115],"about_ca_topic_score_codex":0.0013717833,"about_ca_topic_score_gemma":0.001308817,"teacher_disagreement_score":0.932644,"about_ca_system_score_codex":0.0023015945,"about_ca_system_score_gemma":0.0056422725,"threshold_uncertainty_score":0.35621685},"labels":[],"label_agreement":null},{"id":"W2259072436","doi":"10.15586/jcbmr.2015.10","title":"Overview of Marfan Syndrome: knowns and unknowns","year":2015,"lang":"en","type":"article","venue":"Journal of Controversies in Biomedical Research","topic":"Connective tissue disorders research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Marfan syndrome; Medicine; Disease; Mitral valve prolapse; Medical diagnosis; Intensive care medicine; Bioinformatics; Pathogenesis; Fibrillin; Pathology; Internal medicine; Mitral valve; Biology","score_opus":0.1335543971006092,"score_gpt":0.4502135988238779,"score_spread":0.31665920172326867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2259072436","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00025177025,0.9950413,0.00032431574,0.0022157177,0.00080401724,0.0000060447887,0.000043306638,0.00001766599,0.0012958886],"genre_scores_gemma":[0.0017919026,0.99297136,0.0006953021,0.0012965967,0.0024028588,0.0000120678615,0.00013401794,0.0000051974657,0.00069067796],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99953103,0.000108925495,0.000114873714,0.00009097655,0.00010999265,0.000044227785],"domain_scores_gemma":[0.99875987,0.00064695964,0.00015888999,0.00003549341,0.00026198427,0.00013684639],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010917671,0.0008538171,0.0014646273,0.004793272,0.0005682887,0.0015147735,0.0008423806,0.0016382976,0.0049493336],"category_scores_gemma":[0.0023483604,0.00033281455,0.0006242132,0.0026662836,0.000765695,0.0033050806,0.0009003493,0.0019865627,0.0015400207],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018709696,0.000060935097,0.0015885179,0.012358532,0.00012471441,0.0013392485,0.0002391113,0.00023654949,0.0010693081,0.010009996,0.072994374,0.89979166],"study_design_scores_gemma":[0.000018169518,0.00008665043,0.002136587,0.0067443764,0.0001531534,0.008396066,0.00026338588,0.00012691296,0.00027117218,0.007230452,0.9745336,0.000039509596],"about_ca_topic_score_codex":0.0013862045,"about_ca_topic_score_gemma":0.001652107,"teacher_disagreement_score":0.0049493336,"about_ca_system_score_codex":0.0010181464,"about_ca_system_score_gemma":0.0016106649,"threshold_uncertainty_score":0.016557157},"labels":[],"label_agreement":null},{"id":"W2606523900","doi":"10.15586/jcbmr.2017.18","title":"Recent flaws in Evidence Based Medicine: statin effects in primary prevention and consequences of suspending the treatment.","year":2017,"lang":"en","type":"article","venue":"Journal of Controversies in Biomedical Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Discontinuation; Statin; Medicine; Rosuvastatin; Medical prescription; Intensive care medicine; Disease; Primary prevention; Internal medicine; Pharmacology","score_opus":0.10044384772260126,"score_gpt":0.4432458102614384,"score_spread":0.3428019625388371,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2606523900","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00041595614,0.7792562,0.0023063738,0.20269136,0.013996638,0.000019829806,0.00005767702,0.000035356454,0.0012206472],"genre_scores_gemma":[0.020635353,0.7420623,0.008377117,0.18164545,0.045817513,0.00008519947,0.00012211723,0.000079813784,0.0011751277],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.970859,0.011187296,0.0060297837,0.0023267881,0.00918174,0.00041541574],"domain_scores_gemma":[0.69513714,0.24473338,0.014965503,0.0074382843,0.034698233,0.0030273818],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.074724585,0.0010586597,0.0024537502,0.005061492,0.0014636362,0.0077040703,0.0025194054,0.009260718,0.002427474],"category_scores_gemma":[0.14931917,0.00085713103,0.0020003868,0.0048466055,0.013377792,0.013230801,0.003372294,0.018827654,0.0008929924],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005382562,0.00009767801,0.001998486,0.025908934,0.0014065194,0.0006865333,0.0021566097,0.0008064532,0.0009321366,0.12690863,0.18473886,0.6538209],"study_design_scores_gemma":[0.00012631582,0.00040241284,0.003118157,0.03804327,0.0012338083,0.0023597653,0.0013945113,0.0009896604,0.00067398284,0.18167917,0.76974905,0.00022991507],"about_ca_topic_score_codex":0.002494845,"about_ca_topic_score_gemma":0.0040118913,"teacher_disagreement_score":0.92527544,"about_ca_system_score_codex":0.0061227754,"about_ca_system_score_gemma":0.008076342,"threshold_uncertainty_score":0.39518613},"labels":[],"label_agreement":null}]}